Biothiol-triggered, self-disassembled silica nanobeads for intracellular drug delivery
Source abstract
Abstract
Silica-based nanomaterials have demonstrated great potential in biomedical applications due to their chemical inertness. However, the degradability and endosomal trapping issues remain as rate-limiting barriers during their innovation. In this study, we provide a simple yet novel sol-gel approach to construct the redox-responsive silica nanobeads (ReSiNs), which could be rapidly disassembled upon redox gradient for intracellular drug delivery. The disulfide-linked scaffold of the nanobead was synthesized by employing the dithiobis-(succinimidyl propionate) to bridge (3-aminopropyl)-trimethoxysilane. Such silica matrix could be efficiently disrupted in response to intracellular glutathione, resulting in drug release and collapse of entire nanocarrier. Moreover, the ReSiNs exhibited insignificant cytotoxicity before and after the degradation. These results indicated the potential of using ReSiNs as a novel silica-based, biothiol-degradable nanoplatform for future drug delivery.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Mesoporous Materials and Catalysis · Nanoparticle-Based Drug Delivery · Polymer Surface Interaction Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (49)
Show source-provided references
1. Nanoparticle therapeutics: an emerging treatment modality for cancer10.1038/nrd2614 ↗
2. Delivering nanomedicine to solid tumors10.1038/nrclinonc.2010.139 ↗
3. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging10.1016/j.addr.2009.11.002 ↗
4. Colloidal gold nanoparticles: a novel nanoparticle platform for developing multifunctional tumor-targeted drug delivery vectors10.1002/ddr.20066 ↗
5. Mesoporous silica nanoparticles for drug delivery and biosensing applications10.1002/adfm.200601191 ↗
6. Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems10.1021/nl061412u ↗
7. PH-triggered thermally responsive polymer core-shell nanoparticles for drug delivery10.1002/adma.200401057 ↗
8. Pulsed-high intensity focused ultrasound and low temperature-sensitive liposomes for enhanced targeted drug delivery and antitumor effect10.1158/1078-0432.CCR-06-2443 ↗
9. The effect of nanoparticle size, shape, and surface chemistry on biological systems10.1146/annurev-bioeng-071811-150124 ↗
10. To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery10.1016/j.jconrel.2010.08.027 ↗
11. Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles10.1016/j.jconrel.2013.09.013 ↗
12. Exploiting the enhanced permeability and retention effect for tumor targeting10.1016/j.drudis.2006.07.005 ↗
13. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs
14. Administration, distribution, metabolism and elimination of polymer therapeutics10.1016/j.jconrel.2011.12.021 ↗
15. Photouncaging nanoparticles for MRI and fluorescence imaging in vitro and in vivo10.1021/nn4043699 ↗
16. Design and development of polymeric micelles with cleavable links for intracellular drug delivery10.1016/j.progpolymsci.2012.07.002 ↗
17. Amorphous silica nanohybrids: synthesis, properties and applications10.1016/j.ccr.2009.06.005 ↗
18. Systemic distribution, nuclear entry and cytotoxicity of amorphous nanosilica following topical application10.1016/j.biomaterials.2010.12.042 ↗
19. Multifunctional mesoporous silica nanoparticles for combined therapeutic, diagnostic and targeted action in cancer treatment10.2174/138945011795906624 ↗
20. Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility10.1021/ar3000986 ↗
21. Nanomaterial standards for efficacy and toxicity assessment10.1002/wnan.66 ↗
22. Fluorescent silica nanoparticles with efficient urinary excretion for nanomedicine10.1021/nl803405h ↗
23. Chemical modifications and bioconjugate reactions of nanomaterials for sensing, imaging, drug delivery and therapy10.1039/C3CS60273G ↗
24. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems10.1016/S0168-3659(01)00248-6 ↗
25. Silica nanogelling of environment-responsive PEGylated polyplexes for enhanced stability and intracellular delivery of siRNA10.1016/j.biomaterials.2012.09.077 ↗
26. Targeted drug delivery in cancer cells with red-light photoactivated mesoporous silica nanoparticles10.1021/nl400681f ↗
27. Delivery of small interfering RNA by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers10.1021/nn204102q ↗
28. Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery10.1016/j.jconrel.2011.01.030 ↗
29. Controlled growth of monodisperse silica spheres in the micron size range10.1016/0021-9797(68)90272-5 ↗
30. PH and the recycling of transferrin during receptor-mediated endocytosis10.1073/pnas.80.8.2258 ↗
31. Delivering quantum dots to cells: bioconjugated quantum dots for targeted and nonspecific extracellular and intracellular imaging10.1039/b926512k ↗
32. Influence of silica particle internalization on adhesion and migration of human dermal fibroblasts10.1016/j.biomaterials.2010.07.060 ↗
33. Enzymatic reduction of disulfide bonds in lysosomes: characterization of a gamma-interferon-inducible lysosomal thiol reductase (GILT)10.1073/pnas.97.2.745 ↗
34. Mesoporous silica nanoparticles end-capped with collagen: redox-responsive nanoreservoirs for targeted drug delivery10.1002/anie.201005061 ↗
35. Functional silica nanoparticles for redox-triggered drug/ssDNA Co-delivery10.1002/adhm.201200123 ↗
36. An efficient cell-targeting and intracellular controlled-release drug delivery system based on MSN-PEM-aptamer conjugates10.1039/b907978e ↗
37. Mesoporous silica nanoparticles capped with disulfide-linked PEG gatekeepers for glutathione-mediated controlled release10.1021/am3005225 ↗
38. Encapsulation of water-insoluble drugs in polymer capsules prepared using mesoporous silica templates for intracellular drug delivery10.1002/adma.201001497 ↗
39. Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles10.1002/anie.200501819 ↗
40. Glutathione-induced intracellular release of guests from mesoporous silica nanocontainers with cyclodextrin gatekeepers10.1002/adma.201001417 ↗
41. Multifunctional mesoporous silica nanoparticles for cancer-targeted and controlled drug delivery10.1002/adfm.201201316 ↗
42. Mesoporosity and functional group dependent endocytosis and cytotoxicity of silica nanomaterials10.1021/tx900276u ↗
43. Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells10.1021/ja0645943 ↗
44. The role of glutathione-S-transferase in anti-cancer drug resistance10.1038/sj.onc.1206940 ↗
45. Biodegradable polymeric micelle-encapsulated doxorubicin suppresses tumor metastasis by killing circulating tumor cells10.1039/C4NR07641A ↗
46. Antitumor effects of doxorubicin followed by zoledronic acid in a mouse model of breast cancer10.1093/jnci/djn240 ↗
47. Toward functional screening of cardioactive and cardiotoxic drugs with zebrafish in vivo using pseudodynamic three-dimensional imaging10.1021/ac403877h ↗
48. In vivo multimode Raman imaging reveals concerted molecular composition and distribution changes during yeast cell cycle10.1039/c1cc12350e ↗
49. Stable isotope-labeled raman imaging reveals dynamic proteome localization to lipid droplets in single fission yeast cells10.1016/j.chembiol.2012.08.020 ↗